In Brief: Mallinckrodt/NPB
This article was originally published in The Gray Sheet
Mallinckrodt/NPB: Mallinckrodt completes $28.50-per-share cash tender offer for Nellcor Puritan Bennett with more than 90% of outstanding NPB shares tendered as of Aug. 25. The remaining shares will be converted into the right to receive $28.50 per share in cash to complete the acquisition, Mallinckrodt notes in an Aug. 26 release. Plans for the $1.9 bil. acquisition were announced in July ("The Gray Sheet" July 28, p. 3)...
You may also be interested in...
FDA action awaits Sun’s manufacturing facility in Halol after it failed to adequately address GMP deviations, though India’s top-ranked drug firm appears to have effectively lowered its dependence on the site that has had a patchy compliance run.
In a surprise to the market, Dr Reddy’s and Hikma have prevailed in challenging six method-of-use patents shielding Amarin’s Vascepa in the US, opening the door for a potential at-risk launch that would likely be challenged by the originator.
Duo will study up to four novel preclinical targets identified by Sitryx that may lead to potential new drugs for autoimmune diseases, which Lilly would then commercialize.